Work

1012P Safety, tolerability, and efficacy of nadunolimab in combination with pembrolizumab in patients with solid tumors

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1071

Authors: R. Cohen, S. Jauhari, A. Jimeno, J. Hreno, L. Sun, M. Wallen Öhman, A. Sanfridson, N. Losic, D. Tersago

Institutions: University of Pennsylvania, Florida Cancer Specialists & Research Institute, University of Colorado Cancer Center, University of Colorado Health, University of Colorado Anschutz

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402561020

FWCI: 0.171

Cites:

Cited by: 1

Related to: 10